Symptoms and risk factors for hospitalization of COVID-19 presented in primary care
Authors:
- Susanne RabadySRSusanne Rabady
- Kathryn HoffmannKHKathryn Hoffmann
- Markus BroseMBMarkus Brose
- Oliver LammelOLOliver Lammel
- Stefanie PoggenburgSPStefanie Poggenburg
- Monika Redlberger-FritzMRMonika Redlberger-Fritz
- Karin StiasnyKSKarin Stiasny
- Maria WendlerMWMaria Wendler
- Lukas WeseslindtnerLWLukas Weseslindtner
- Sonja ZehetmayerSZSonja Zehetmayer
- Gustav KamenskiGKGustav Kamenski
Open Access
- 11 February 2022
- journal article
- research article
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 134 (9-10) , 335-343
Abstract
Summary: Objective: To increase knowledge of discrete symptoms shall help to avoid misinterpretation of test results and to gain better understanding of associations between early symptoms and severe disease to provide additional criteria for targeted early interventions.Design: Retrospective observational study.Setting: Austrian GP practices in the year 2020, patients above 18 years were included.Participants: We recruited 25 practices which included 295 participants with a positive SARS-CoV‑2 test.Main outcome measures: Data collection comprised basic demographic data, risk factors and the recording of symptoms at several points in time in the course of the illness. Descriptive analyses for possible associations between demographics and symptoms were conducted by means of cross tabulation. Group differences (hospitalized yes/no) were assessed using Fisher’s exact test. The significance level was set to 0.05; due to the observational character of the study, no adjustment for multiplicity was performed.Results: Only one third of patients report symptoms generally understood to be typical for COVID‑19. Most patients presented with unspecific complaints. We found symptoms indicating complicated disease, depending on when they appear. The number of symptoms may be a predictor for the need of hospital care. More than 50% of patients still experience symptoms 14 days after onset.Conclusion: Unspecific symptoms are valuable indicators in the detection of early COVID‑19 disease that practitioners and the general public should be aware of also in the interpretation of low sensitivity tests. Monitoring patients using the indicators we identified may help to identify patients who are likely to profit from early intervention.Keywords
All Related Versions
Funding Information
- steirische akademie für allgemeinmedizin (none)
- Karl Landsteiner Privatuniversität für Gesundheitswissenschaften
This publication has 19 references indexed in Scilit:
- COVID-19 mild cases determination from correlating COVID-line calls to reported casesmedRxiv, 2020
- Management of post-acute covid-19 in primary careBMJ, 2020
- Quantifying additional COVID-19 symptoms will save livesThe Lancet, 2020
- Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysisJournal of Infection, 2020
- Real-time tracking of self-reported symptoms to predict potential COVID-19Nature Medicine, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Covid-19: a remote assessment in primary careBMJ, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020